Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FHKW2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,763
Award facts
- Contract value 100% obligated
- $16,762.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,762.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 68 mg Nexplanon implants. This delivery order, issued on January 20, 2026, with an ultimate completion date of February 10, 2026, contains no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy established to support Department of Defense medical supply requirements worldwide.
DMS Pharmaceutical Group has demonstrated substantial contracting capacity within the federal pharmaceutical supply chain, with the parent PPV-G GEN V contract valued at $499,999,999 and extending through December 31, 2036. The contractor's established performance on numerous delivery orders spanning diverse therapeutic categories—including oncology treatments, biologics, vaccines, and specialty pharmaceuticals—positions it as a critical supplier for military healthcare facilities. This specific delivery order for contraceptive implants reflects the company's capability to provide specialized pharmaceutical products essential to Defense Department medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FHKW2?
SPE2DR26FHKW2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FHKW2 worth?
The government has obligated $16,763 on SPE2DR26FHKW2.
Is contract SPE2DR26FHKW2 an order under another contract?
Yes. SPE2DR26FHKW2 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKW2 competed?
The extent of competition for SPE2DR26FHKW2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award